You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 11, November 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

OK-432 Therapy for Lymphangiomas

Richard J. H. Smith, MD; Diane K. Burke, RN; Yutaka Sato, MD; Rolland I. Poust, PhD; Ken Kimura, MD; Nancy M. Bauman, MD

Arch Otolaryngol Head Neck Surg. 1996;122(11):1195-1199.


Abstract

Objective
To assess the efficacy of OK-432 sclerotherapy in the treatment of lymphangiomas.

Design
Nonrandomized trial; follow-up, 4 to 29 months.

Setting
Academic tertiary referral medical center.

Patients
Six children with presumed lymphangiomas; age range at initial treatment, 1 month to 7 years 10 months.

Intervention
Fluoroscopically guided cyst aspiration, cystography, and injection of OK-432.

Outcome Measures
Clinical and radiographic comparisons before and after therapy.

Results
Complete response in 2 macrocystic lymphangiomas; no response in 3 microcystic lymphangiomas; and no response in 1 venous malformation.

Conclusion
OK-432 sclerotherapy may be effective treatment for macrocystic lymphangiomas.

Arch Otolaryngol Head Neck Surg. 1996;122:1195-1199



Author Affiliations

From the Departments of Otolaryngology (Drs Smith and Bauman and Ms Burke), Radiology (Dr Sato), and Surgery (Dr Kimura) and the College of Pharmacy (Dr Poust), University of Iowa, Iowa City.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

OK-432 Sclerotherapy of Plunging Ranula in 21 Patients: It Can Be a Substitute for Surgery.
Rho et al.
Am. J. Neuroradiol. 2006;27:1090-1095.
ABSTRACT | FULL TEXT  

Lymphocytopenia in Children With Lymphatic Malformation
Tempero et al.
Arch Otolaryngol Head Neck Surg 2006;132:93-97.
ABSTRACT | FULL TEXT  

Altered Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor Levels in Lymphangioma Pathogenesis and Clinical Recurrence
Sidle et al.
Arch Otolaryngol Head Neck Surg 2005;131:990-995.
ABSTRACT | FULL TEXT  

Pediatric Parotid Masses
Orvidas et al.
Arch Otolaryngol Head Neck Surg 2000;126:177-184.
ABSTRACT | FULL TEXT  

Cystic Hygroma of the Skull Base
Tibesar et al.
Arch Otolaryngol Head Neck Surg 1999;125:1390-1393.
ABSTRACT | FULL TEXT  

Total, Subtotal, and Partial Surgical Removal of Cervicofacial Lymphangiomas
Riechelmann et al.
Arch Otolaryngol Head Neck Surg 1999;125:643-648.
ABSTRACT | FULL TEXT  

High Angiogenic Activity in Cells Isolated From Cystic Hygroma: Role of bFGF
Maddalozzo et al.
Arch Otolaryngol Head Neck Surg 1999;125:45-48.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.